Earth Science Tech, Inc. (ETST) Stock Price & Analysis
Earth Science Tech, Inc. (ETST) rose 0.00% to USD 0.09 as of September 8, 2026 at 17:06 UTC, according to Nexqual real-time market data.
ETST last closed at USD 0.09; the session ranged USD 0.09–0.09 on volume of 29,011 shares. Market capitalization is —, with a 52-week range of USD 0–0.24 (OID). Source: Nexqual, September 8, 2026 at 17:06 UTC.
Key Statistics (as of September 8, 2026 at 17:06 UTC)
| Price | USD 0.09 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 0.09 |
| Open | USD 0.09 |
| Day Range | USD 0.09 – 0.09 |
| 52-Week Range | USD 0 – 0.24 |
| Volume | 29,011 shares |
| Market Cap | — |
| Exchange | OID |
Technical Analysis (ETST)
Nexqual's technical model rates ETST "SELL" based on 1 bullish and 5 bearish signals across 127 daily candles, as of September 8, 2026 at 17:06 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 37.75 (neutral) |
| vs SMA50 | Below (USD 0.12) |
| MACD | -0.01 (negative) |
From Earth Science Tech, Inc.'s Latest SEC 10-K Filing (filed 2026-06-18)
Key Strengths & Strategy (as disclosed to the SEC)
- Our approach focuses on high-conversion digital acquisition, strategic demographic targeting, and the utilization of proprietary technology to drive patient retention and brand loyalty across our diverse subsidiaries.
- The Company's principal operating strategy is to build a vertically integrated healthcare platform that combines compounding pharmacy operations, telemedicine platforms, clinical support, and patient fulfillment.
- Our ability to compete effectively is predicated on our unique vertical integration, which allows us to offer a value added healthcare experience.   Health and wellness   In the pharmaceutical compounding and telemedicine sectors the Company faces intense competition from both traditional brick-and-mortar pharmacies and a rapidly expanding cohort of digital health platforms.
- As we expand our geographical footprint, we continuously monitor state-level licensure requirements to ensure compliant dispensing across all active jurisdictions.   Telemedicine Regulation   The Company's digital health operations, facilitated through Peaks, DOC and our integrated pharmacy platforms, navigate a multifaceted landscape of federal and state laws.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| CANL | CannLabs Inc. | USD 0 | ▲ 0% |
| NSPDF | NATURALLY SPLENDID ENTERPRISES | USD 0.04 | ▲ 0% |
| GBHPF | Global Hemp Group Inc | USD 0 | ▲ 0% |
| RSSFF | Affinor Growers, Inc. | USD 0.03 | ▼ 21.05% |
| GRWC | Grow Capital, Inc. | USD 0.08 | ▼ 24% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 17:06 UTC. This page is informational and not investment advice.